Mutually aggravating complications in the development of hepatorenal syndrome in decompensated portal hypertension
Open Access
- 27 June 2026
- journal article
- Published by Publishing House Zaslavsky in EMERGENCY MEDICINE
- Vol. 22 (4) , 376-382
Abstract
Background. Hepatorenal syndrome (HRS) developing in the setting of decompensated portal hypertension (PH) is characterized by progressive renal failure, elevated serum creatinine levels, and worsening oliguria. HRS occurs in approximately one-third of patients with Child-Pugh class C liver cirrhosis. The purpose was to optimize early diagnosis and treatment, as well as to identify risk factors for the development of HRS and associated mortality. Materials and methods. A total of 126 medical records of patients with decompensated PH treated at the Kyiv City Emergency Hospital and the Department of Surgery, Dental Faculty, Bogomolets National Medical University, between 2022 and 2024 were analyzed. HRS was diagnosed in 51 (40.5 %) cases. Diagnostic criteria included an increase in serum creatinine > 150 µmol/L (1.69 mg/dL) or ≥ 26.5 µmol/L (0.3 mg/dL) within 48 hours in the presence of oliguria and absence of other signs of intrinsic renal injury, particularly hematuria. Patients were divided into two groups. The first group included 24 (47.1 %) patients in whom HRS and community-acquired spontaneous bacterial peritonitis (SBP) were diagnosed within the first 24 hours, and a restrictive transfusion strategy was applied. The second group comprised 27 (52.9 %) participants in whom HRS and nosocomial SBP were diagnosed on days 3–5 of hospitalization, and a liberal transfusion strategy was used. The impact of transfusion strategy, ascites severity, and SBP as mutually aggravating factors in HRS development was assessed. Results. Analysis showed that the combination of large-volume ascites, SBP, and a liberal transfusion strategy forms an unfavorable prognostic complex associated with a significantly increased risk of mortality. HRS development was more frequently associated with large-volume ascites (70.8 %), nosocomial SBP (37.0 %), and a liberal transfusion strategy (52.9 %). Among 126 patients, 27 (21.4 %) underwent surgery. In the postoperative period, HRS developed in 1 (4.2 %) patient in the first group and in 2 (7.4 %) patients in the second group. Overall mortality was 74.5 % (n = 38), with 14 deaths (58.3 %) in the first group and 24 (88.9 %) in the second group (p = 0.03). According to ROC analysis, the model demonstrated high predictive performance for mortality (AUC = 0.909; 95% CI 0.831–0.987), confirming strong discriminative ability for risk stratification in patients with HRS. Conclusions. HRS is a severe complication of decompensated PH associated with high mortality. A liberal transfusion strategy, severe ascites, and SBP increase the risk of its development and progression. Early monitoring of urine output and serum creatinine levels is critical for timely diagnosis, prevention, and management of HRS.Keywords
This publication has 35 references indexed in Scilit:
- Hepatorenal Syndrome: Updates on Definition, Classification, Pathophysiology and Treatment OptionsTechniques in Vascular and Interventional Radiology, 2025
- Management of acute variceal bleeding: updated APASL guidelinesHepatology International, 2025
- Transjugular Intrahepatic Portosystemic Shunt for Preventing Rebleeding of Esophageal Varices in Patients with Portal Cavernous TransformationDigestive Diseases and Sciences, 2025
- Clinical outcomes and care for spontaneous bacterial peritonitis: A national cohort studyHepatology, 2025
- Terlipressin‐induced skin necrosis in cirrhotic patients—A case report and comprehensive literature reviewClinical Case Reports, 2024
- Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meetingJournal of Hepatology, 2024
- Use of albumin infusion for cirrhosis-related complications: An international position statementJHEP Reports, 2023
- Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology, 2021
- Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevanceJournal of Hepatology, 2014
- Hepatorenal SyndromeSeminars in Liver Disease, 1997